Search research articles
Contact Us
Filters
Showing results (461-470 of 497) with videos related to
Page
of 50
Sort By:
Kidney International
|
March 23, 2005
Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program
Tarek M El-Achkar, Suzanne E Ohmit, Peter A McCullough, et al.
Journal of the American Society of Nephrology : JASN
|
May 6, 2005
Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study
Zhongxin Zhang, Shahnaz Shahinfar, William F Keane, et al.
Ugeskrift for Laeger
|
October 17, 2001
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]
H H Parving, B M Brenner, M E Cooper, et al.
The New England Journal of Medicine
|
September 22, 2001
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
B M Brenner, M E Cooper, D de Zeeuw, et al.
Journal of the American Society of Nephrology : JASN
|
October 1, 1991
Adjunctive therapy with intravenous human immunoglobulin G improves survival of patients with acute renal failure
W F Keane, C A Hirata-Dulas, M L Bullock, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
July 1, 1995
The pharmacokinetics of losartan in renal insufficiency
D A Sica, M W Lo, W C Shaw, et al.
Oncogene
|
June 10, 2014
Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer
X Chen, T Paranjape, C Stahlhut, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 28, 2003
Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP)
Wendy Weinstock Brown, Rosalind M Peters, Suzanne E Ohmit, et al.
Diabetes Care
|
December 12, 2007
Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study
Andrew M Tershakovec, William F Keane, Zhongxin Zhang, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1992
Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease
C E Halstenson, M O Wong, C S Herman, et al.
Page
of 50
Search research articles
Search
Showing results (461-470 of 497) with videos related to
Sort By:
Page
of 50
Kidney International
|
March 23, 2005
Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program
Tarek M El-Achkar, Suzanne E Ohmit, Peter A McCullough, et al.
Journal of the American Society of Nephrology : JASN
|
May 6, 2005
Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study
Zhongxin Zhang, Shahnaz Shahinfar, William F Keane, et al.
Ugeskrift for Laeger
|
October 17, 2001
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]
H H Parving, B M Brenner, M E Cooper, et al.
The New England Journal of Medicine
|
September 22, 2001
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
B M Brenner, M E Cooper, D de Zeeuw, et al.
Journal of the American Society of Nephrology : JASN
|
October 1, 1991
Adjunctive therapy with intravenous human immunoglobulin G improves survival of patients with acute renal failure
W F Keane, C A Hirata-Dulas, M L Bullock, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
July 1, 1995
The pharmacokinetics of losartan in renal insufficiency
D A Sica, M W Lo, W C Shaw, et al.
Oncogene
|
June 10, 2014
Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer
X Chen, T Paranjape, C Stahlhut, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 28, 2003
Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP)
Wendy Weinstock Brown, Rosalind M Peters, Suzanne E Ohmit, et al.
Diabetes Care
|
December 12, 2007
Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study
Andrew M Tershakovec, William F Keane, Zhongxin Zhang, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1992
Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease
C E Halstenson, M O Wong, C S Herman, et al.
Page
of 50